Verona Pharma plc - stock earnings
VRNA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -14.7 million USD | ? USD |
| 2023Q2 | -8.8 million USD | ? USD |
| 2023Q1 | -16.7 million USD | ? USD |
| 2022Q4 | -10.5 million USD | 458000 USD |
| 2022Q3 | -15.6 million USD | ? USD |
| 2022Q2 | -17.8 million USD | ? USD |
| 2022Q1 | -24.8 million USD | ? USD |
| 2021Q4 | -23.3 million USD | 40.0 million USD |
| 2021Q3 | 11.1 million USD | 40.0 million USD |
| 2021Q2 | -22.1 million USD | ? USD |
| 2021Q1 | -21.3 million USD | ? USD |
| 2020Q4 | -23.7 million USD | ? USD |
| 2020Q3 | -19.9 million USD | ? USD |
| 2020Q2 | -9.0 million USD | 2351 USD |
| 2020Q1 | -11.8 million USD | ? USD |
| 2019Q4 | -7.4 million USD | 2351 USD |
| 2019Q3 | -12.5 million USD | ? USD |
| 2019Q2 | -11.4 million USD | ? USD |
| 2019Q1 | -7.1 million USD | ? USD |
| 2018Q4 | -3.2 million USD | 2783 USD |
| 2018Q3 | -3.0 million USD | ? USD |
| 2018Q2 | 798818 USD | ? USD |
| 2018Q1 | -21.3 million USD | ? USD |
| 2017Q4 | -8.6 million USD | 1.8 million USD |
| 2017Q3 | -12.2 million USD | ? USD |
| 2017Q2 | -4.2 million USD | ? USD |
| 2017Q1 | -2.4 million USD | ? USD |
| 2016Q4 | -671241 USD | ? USD |
| 2016Q3 | -3.2 million USD | ? USD |
| 2016Q2 | -1.1 million USD | ? USD |
VRNA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -54.4 million USD | 458000 USD |
| 2022 | -68.7 million USD | 458000 USD |
| 2021 | -55.6 million USD | 40.0 million USD |
| 2020 | -65.1 million USD | 2351 USD |
| 2019 | -41.9 million USD | 2351 USD |
| 2018 | -25.3 million USD | 2783 USD |
| 2017 | -27.7 million USD | 1.8 million USD |
| 2016 | -6.2 million USD | ? USD |
| 2015 | -11.0 million USD | ? USD |
| 2014 | -4.3 million USD | ? USD |
| 2013 | -4.2 million USD | ? USD |
| 2012 | -4.1 million USD | ? USD |
| 2011 | -2.7 million USD | ? USD |
| 2010 | -2.9 million USD | ? USD |
| 2009 | -2.6 million USD | ? USD |
| 2008 | -2.0 million USD | ? USD |
| 2007 | -2.4 million USD | ? USD |
| 2006 | -1.2 million USD | ? USD |
| 2005 | 44738 USD | ? USD |
VRNA
Price: $15.69
52 week price:
Earnings Per Share: -0.72 USD
P/E Ratio: -30.25
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 555000
Ebitda: -10.7 millionMarket Capitalization: 1.3 billion